30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis - Enrique M. Ocio; Aurore Perrot; Philippe Moreau; Maria‐Victoria Mateos; Sara Bringhen; Joaquín Martínez‐López; Lionel Karlin; Song‐Yau Wang; Corina Oprea; Yi Li; Ercem Kodas; Jesus San‐Miguel (HemaSphere)